- Home
- / Dongkoo Bio&Pharma
Dongkoo Bio&Pharma
Stock Price
₩5.6 K
2024-10-29
Market Capitalization
₩149.6 B
2024-10-29
Revenue
₩249.3 B
FY, 2024
Dongkoo Bio&Pharma Summary
Company Summary
- Overview
- Dongkoo Bio&Pharma is a pharmaceutical company specializing in dermatology and urology treatments. It offers general and prescribed medicines including digestants, analgesics, antipyretics, antihistamines, decongestants, probiotics, etc. Additionally, the company offers skincare cosmetics.
- Type
- Public
- Status
- Active
- Founded
- 1970
- HQ
- KR | view all locations
- Website
- http://www.dongkoo.com/
- Cybersecurity rating
Table of Contents
LocationsView all
2 locations detected
Seoul HQ
Korea (Republic of)
Beobwon-ro, Seocho 3(sam)-dong, Seocho-gu
Hwaseong-si, Gyeonggi-do
Korea (Republic of)
18 Jeyakgongdan 2-gil, Hyangnam-eup
Dongkoo Bio&Pharma Financials
Summary Financials
- Revenue (Q3, 2025)
- ₩62.0B
- Gross profit (Q3, 2025)
- ₩38.4B
- Net income (Q3, 2025)
- (₩1.6B)
- Cash (Q3, 2025)
- ₩11.0B
- EBIT (Q3, 2025)
- (₩493.1M)
- Enterprise value
- $245.6B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026